Ridgeback Asset Management LP
Legal Name: RIDGEBACK ASSET MANAGEMENT LP
Full Contact Details
Ridgeback Asset Management LP
75 9TH AVENUE, 5TH FLOOR, NEW YORK, NY
212 624 2600
646 349 4770
Other Info
Ridgeback Asset Management LP, a DE Limited Partnership with 6 employees, including 3 in advisory roles, has successfully served 2 clients. Their SEC status is Approved and its registration date was Sep 12, 2017.
Ridgeback Capital Management
Wayne Holman Ridgeback Capital Investments Medicine ADAP, Adaptimmune, CLLS, ALCLS, Cellectis, FGEN, Fibrogen, MGNX, Macrogenics, AGTC, applied genetic technologies, SGMO, Sangamo, Trillium, TRIL, IRWD, Ironwood, UTHR, United Therapeautics, BMRN, Biomarin, CELG, Celgene, CLDX, Celldex, CMRX, Chimeri…
Direct Owners
-
CHRISTOPHER ACHILLES NONAS
CHIEF COMPLIANCE OFFICER owns less than 5%
-
RIDGEBACK ASSET MANAGEMENT GP LLC
GENERAL PARTNER owns less than 5%
-
WAYNE GEORGE HOLMAN
CHIEF EXECUTIVE OFFICER, LIMITED PARTNER owns 75% or more
Indirect Owners
-
WAYNE GEORGE HOLMAN
MANAGING MEMBER owns 75% or more
-
WENDY PATRICE COMMINS
MEMBER
Prime Brokers
-
MORGAN STANLEY
United States